Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD), Ionis Pharmaceuticals (IONS) and DENTSPLY SIRONA (XRAY)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Revolution Medicines (RVMD – Research Report), Ionis Pharmaceuticals (IONS – Research Report) and DENTSPLY SIRONA (XRAY – Research Report).
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Revolution Medicines (RVMD)
LifeSci Capital analyst Charles Zhu maintained a Buy rating on Revolution Medicines today and set a price target of $104.00. The company’s shares closed last Thursday at $123.27.
According to TipRanks.com, Zhu is a 5-star analyst with an average return of
Currently, the analyst consensus on Revolution Medicines is a Strong Buy with an average price target of $89.56, implying a -25.8% downside from current levels. In a report issued on January 8, TipRanks – Google also initiated coverage with a Buy rating on the stock with a $116.00 price target.
See the top stocks recommended by analysts >>
Ionis Pharmaceuticals (IONS)
In a report released today, Jason Gerberry from Bank of America Securities maintained a Buy rating on Ionis Pharmaceuticals, with a price target of $100.00. The company’s shares closed last Thursday at $77.21.
According to TipRanks.com, Gerberry is a 5-star analyst with an average return of
Currently, the analyst consensus on Ionis Pharmaceuticals is a Strong Buy with an average price target of $94.92, implying a 19.8% upside from current levels. In a report issued on January 7, TipRanks – Google also upgraded the stock to Buy with a $95.00 price target.
DENTSPLY SIRONA (XRAY)
Bank of America Securities analyst Allen Lutz maintained a Hold rating on DENTSPLY SIRONA today. The company’s shares closed last Thursday at $12.58.
According to TipRanks.com, Lutz is a 5-star analyst with an average return of
DENTSPLY SIRONA has an analyst consensus of Hold, with a price target consensus of $13.00, which is a 5.9% upside from current levels. In a report issued on January 14, TipRanks – PerPlexity also upgraded the stock to Hold with a $13.00 price target.
